Evolution of the Average Target: Exor N.V.

Evolution of the Target Price: Exor N.V.

Changes in Analyst Recommendations: Exor N.V.

e2323cac8138edab9d147.NE36Jn6KLUAJogNgVZTwnJ9xRw_0Mv_Cz6xQ_GUPY70.cwGPdTXuQwRo2Fc1Gd-V8vwzKUyNVJ6nn_YkmwhWLNhNO7JCP9JrF07jUg~ad74cf7309b81f1c675ef912681ba958
03/09 AlphaValue/Baader Europe Updates EPS Forecasts for Exor on Expected Dividend Income MT
03/09 Exor: EPS upgrade (2025: +45.4%, 2026: +54.0%) Alphavalue
16/02 AlphaValue/Baader Europe Adjusts Exor Earnings Estimates After Stellantis' Preliminary H2 2025 Results MT
14/02 Exor: EPS cut (2025: -34.6%, 2026: -29.4%) Alphavalue
27/09/25 Exor: Exor H1 2025: Strategy still in waiting Alphavalue
17/09/25 The day the Fed resumed its rate cuts Zonebourse
02/07/25 Exor: Target upgrade by 17.8% Alphavalue
28/03/25 Exor: Exor's strategic moves: Market lagging behind Alphavalue
26/03/25 BNP Paribas Exane Upgrades Exor to Outperform MT
03/12/24 Exor: Adjustments following Exor's reclassification as an Investment Entity Alphavalue
03/12/24 Exor: Stellantis' woes likely to spill over to Exor Alphavalue
02/10/24 KBC Securities Starts Exor at Buy MT
26/09/24 Exor: NAV progresses further Alphavalue
23/07/24 AlphaValue/Baader Europe Upgrades Exor to Buy, Raises PT MT
23/07/24 Exor: Opinion change, from Add to Buy Alphavalue
12/04/24 Exor: Stellantis and Ferrari continue to push Exor forward Alphavalue
05/03/24 Exor: Exor is adept for recovery bets Alphavalue
20/02/24 Exor: NAV cut by -8.8% Alphavalue
01/12/23 Exor : Exor reiterates its faith in Philips Alphavalue
15/09/23 Exor : Exor pushes the throttle Alphavalue
17/08/23 Exor : Exor delivers on its diversification strategy Alphavalue
04/07/23 Exor : EPS upgrade (2022: -20.5%, 2023: +13.5%) Alphavalue
30/05/23 Analysts recommendations: Alliant Energy, Coinbase, Constellation Brands, Medtronic... Zonebourse
18/04/23 Exor : 2022: Another milestone year in Exor's Equity Story Alphavalue
20/01/23 Exor : All eyes on Juventus with Exor and Stellantis potentially impacted Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+58.21%
+24.76%
-1.56%
+17.86%
+10.99%
+16.38%
+13.28%
+2.75%
+3.83%
Average +16.28%
Weighted average by Cap. +15.86%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
71.20EUR
Average target price
108.38EUR
Spread / Average Target
+52.21%
High Price Target
120.00EUR
Spread / Highest target
+68.54%
Low Price Target
91.00EUR
Spread / Lowest Target
+27.81%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!